A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Clinical trial NCT07558915 · RECRUITING

Trial details

NCT number: NCT07558915
Sponsor: Genentech, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2026-06-23
Primary completion: 2030-07-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.